EUROAPI supports Sanofi’s mRNA vaccine projects with lipid nanoparticle development
EUROAPI has expanded a collaboration with Sanofi, which will see it support Sanofi's mRNA vaccine platform with the development of lipid nanoparticles.
Archives for May 30, 2022
CureVac increases focus on cancer vaccine development
A partnership with myNEO represents the first step in CureVac’s targeted expansion of its mRNA approach for the development of cancer vaccines, says the company.
Pfizer opens access to portfolio for low-income countries
The company will provide its current and future portfolio of patented medicines to 45 lower-income countries, but the move is not without controversy.
Sosei Heptares expands R&D capabilities in UK life science hub
Sosei Heptares builds out its UK R&D presence by moving into a second location in Cambridge.